BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Nov 7, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-11-05

Reporting Person: FUCHS HENRY J (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-05	Common Stock	M	10000	$11.05	Acquired	62277	Direct
2012-11-05	Common Stock	S	10000	$46.00	Disposed	52277	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-11-05	Stock Option (right to buy)	$11.05	M	10000	Disposed	2019-03-01	Common Stock (10000)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 14, 2012.

F2: Original option grant vests 6/48ths on September 2, 2009 and 1/48th on the 2nd of each month thereafter.